FIRSTDRUG in the worldapproved to treat Favipiravir-basedCOVID-19Learn moreHBV is the leading cause of cancer-related morbidity and mortality worldwide First ORAL drugAPPROVED to treatCOVID-19Learn moreAVIFAVIR delivered toover 200,000 patients& 16 countries worldwideLearn more 12760 High Bluff Dr., San Diego, CA, 92130 CHR101 has the potential to eradicate HBV and to cure chronically infected HBV patients Learn more about our news and events in 2020
